Cargando…
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity
The opportunistic pathogen Pseudomonas aeruginosa is one of leading causes of disability and mortality worldwide and the world health organisation has listed it with the highest priority for the need of new antimicrobial therapies. P. aeruginosa strains responsible for the poorest clinical outcomes...
Autores principales: | Foulkes, Daniel M., McLean, Keri, Sloniecka, Marta, Rustidge, Sophie, Byrne, Dominic P., Haneef, Atikah S., Winstanley, Craig, Berry, Neil, Fernig, David G., Kaye, Stephen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788569/ https://www.ncbi.nlm.nih.gov/pubmed/36504127 http://dx.doi.org/10.1042/BCJ20220527 |
Ejemplares similares
-
Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections
por: Foulkes, Daniel M., et al.
Publicado: (2019) -
A pipeline to evaluate inhibitors of the Pseudomonas aeruginosa exotoxin U
por: Foulkes, Daniel M., et al.
Publicado: (2021) -
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018) -
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017) -
Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland
por: Michalska, Anna Diana, et al.
Publicado: (2015)